HCM
BHC icon

Highbridge Capital Management’s Bausch Health BHC Stock Holding History

Highbridge Capital Management’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-125,900
Closed -$2.93M – 508
2018
Q2 		$2.93M Sell
125,900
-302,500
-71% -$6.26M 0.06% 335
2018
Q1 		$6.82M Sell
428,400
-11,300
-3% -$210K 0.11% 231
2017
Q4 		$9.13M Buy
439,700
+403,300
+1,108% +$6.4M 0.16% 176
2017
Q3 		$520K Sell
36,400
-34,200
-48% -$517K 0.01% 901
2017
Q2 		$1.22M Buy
70,600
+60,600
+606% +$726K 0.02% 523
2017
Q1 		$111K Sell
10,000
-2,200
-18% -$30.3K ﹤0.01% 1373
2016
Q4 		$176K Hold
12,200
– – ﹤0.01% 1150
2016
Q3 		$298K Buy
+12,200
New +$316K ﹤0.01% 1012
2016
Q2 		– Sell
-16,500
Closed -$435K – 1405
2016
Q1 		$435K Buy
+16,500
New +$1.22M 0.01% 1034

Other funds holding BHC

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

Highbridge Capital Management's BHC Position: Q3 2018 in Review

Highbridge Capital Management sold out of Bausch Health (BHC) in Q3 2018, closing a stake of 39,940 shares — an estimated $915K sold.

Highbridge Capital Management first reported a position in BHC in Q2 2014 and held it in 10 quarters. The position peaked at $38.6M in Q2 2014. 332 funds tracked by Wall St. Rank hold BHC as of Q3 2018.

  • Highbridge Capital Management reported no remaining Bausch Health position as of Q3 2018 after selling out during the quarter.
  • Highbridge Capital Management sold 39,940 Bausch Health shares in Q3 2018, an estimated $915K.
  • Highbridge Capital Management first reported a position in Bausch Health in Q2 2014 and held it in 10 quarters.
  • Highbridge Capital Management's Bausch Health position peaked at $38.6M in Q2 2014.
  • 332 funds tracked by Wall St. Rank held Bausch Health as of Q3 2018.

Based on Highbridge Capital Management's 13F filing for Q3 2018, filed 13 Nov 2018.